Oral Psoriasis Treatment Adherence and Intervention Study

Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Jul 27, 2016

Keywords

ClinConnect Summary

Psoriasis is a common, chronic inflammatory disease that has a major impact on patients' quality of life. Patients' response to treatment is variable. Poor adherence to topical, oral and biologic psoriasis treatments is common and may account for poor responses.1, 2 Many psoriasis patients do not even fill their prescriptions.3 Electronic monitoring of adherence provides the most detailed and accurate way to assess adherence. While studies using electronic monitors have assessed adherence to topical psoriasis treatments and to biologics, adherence to oral psoriasis treatments is not as well...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Any male or female 12 years or older of age with a diagnosis of psoriasis who is prescribed methotrexate by a dermatologist will be eligible for participation.
• • Greater than 10% of body surface involvement for psoriasis.
• • Subject is capable of understanding and willing to provide a signed and dated written voluntary informed consent before any protocol specific procedures are performed.
• • The subject is able to complete the study and comply with study instructions, including attending all study visits.
• Exclusion Criteria:
• • Individuals younger than 12 years of age.
• • Known allergy or sensitivity to methotrexate.
• • Inability to complete all study-related visits, or inability to complete the Internet survey due to inadequate Internet access.
• • Introduction of any other prescription medication, topical or systemic, for psoriasis while participating in the study.